FDA warns J&J unit over device marketing

08/24/2010 | Los Angeles Times (tiered subscription model)

The FDA issued a warning letter to DePuy Orthopaedics saying that the Johnson & Johnson unit is selling an unapproved device, the TruMatch Personalized Solution System, and marketing another device, the Corail Hip System, for off-label uses. A DePuy statement said the company is "reviewing the letter to understand the FDA's concerns and will respond to their request for information."

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ